Qinghai Biotech Pharmaceutical Group Limited (HKG:0876)

HKG:0876 Revenue

Qinghai Biotech Pharmaceutical Group had revenue of 284.59M HKD in the half year ending June 30, 2026, with 221.51% growth. This brings the company's revenue in the last twelve months to 85.50M, down -48.62% year-over-year. In the year 2025, Qinghai Biotech Pharmaceutical Group had annual revenue of 139.11M, down -24.95%.

• Revenue (ttm): 85.50M
• Revenue Growth: -48.62%
• P/S Ratio: 2.18
• Revenue / Employee: 63.81K
• Employees: 1,340
• Market Cap: 186.54M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	139.11M	-46.25M	-24.95%
Dec 31, 2024	185.36M	-525.00K	-0.28%
Dec 31, 2023	185.88M	-5.62M	-2.93%
Dec 31, 2022	191.50M	-18.13M	-8.65%
Dec 31, 2021	209.63M	25.82M	14.04%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 1, 2026

Data Sources Report a data error